Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Pelion SA (PELIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Pelion SA historical data, for real-time data please try another search
58.80 0.00    0.00%
07/06 - Closed. Currency in PLN ( Disclaimer )
Type:  Equity
Market:  Poland
ISIN:  PLMEDCS00015 
  • Volume: 0
  • Bid/Ask: 58.81 / 58.94
  • Day's Range: 58.80 - 58.98
Pelion SA 58.80 0.00 0.00%

Pelion SA Company Profile

 
Get an in-depth profile of Pelion SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

8973

Equity Type

ORD

Pelion S.A. engages in the trade of pharmaceuticals, cosmetics, and parapharmaceuticals in Poland. It operates through Wholesale, Retail, and Hospital supplies and logistics services segments. The company is involved in the wholesale and retail sale of pharmaceuticals to pharmacies, outpatient clinics, medical stores, etc., as well as in-patient healthcare institutions, hospitals, and wholesalers; and retail sale of dermocosmetics, such as personal care cosmetics, make-up products, nail care products, hair and body care products, and fragrances. It operates approximately 900 outlets under the DOZ Apteki dbam o zdrowie brand name; 300 beauty stores under the Natura name; 330 own and franchise pharmacies under the Gintarine Vaistine and Norfos Vaistine brands; 140 BVG partner pharmacies; e-pharmacies, including doz.pl and vaistine; and beauty e-stores comprising drogerienatura.pl and dozdrogeria.pl, as well as publishes Farmakoekonomika szpitalna, a quarterly magazine distributed to hospitals and pharmacies. The company also offers logistics services related to the management, warehousing, and distribution of drugs for the pharmaceutical industry; and business process outsourcing services, such as outsourcing of accounting and reporting, HR and payroll, management accounting, tax, financing process support, and business advisory services, as well as consolidation of financial statements. In addition, it provides credit risk management, contract-based manufacturing, and medical services, as well as pharmaceutical insurance products based on private drug refund schemes; develops and commercializes anti-atherogenic drugs, dermocosmetics, food and dietary supplements, and galenic preparations; and designs and develops healthcare solutions. Pelion S.A. was formerly known as Polska Grupa Farmaceutyczna SA and changed its name to Pelion S.A. in November 2011. The company was founded in 1990 and is based in Lódz, Poland.

Contact Information

Address ul. Zbaszynska 3
Lódz, 91-342
Poland
Phone 48 42 200 7805
Fax 48 42 200 7535
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PELIO Comments

Write your thoughts about Pelion SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email